Safety/tolerability and preliminary antitumour activity of sitravatinib plus tislelizumab in patients with advanced platinum-resistant ovarian cancer (PROC)

Jeff Goh, Jermaine Coward, Bo Gao, Ines Pires da Silva, Mark Voskoboynik, Daphne Day, Amy Louise Body, Hui K. Gan, Cheng Chen, Xiao Xiang, Cong Fei, Liu Yang, Michael Millward

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

1 Citation (Web of Science)
Original languageEnglish
Pages (from-to)65-65
Number of pages1
JournalAsia-Pacific Journal of Clinical Oncology
Publication statusPublished - Nov 2021

Cite this